STAG2 as a Prognostic Biomarker in Low Grade Non-Muscle Invasive Bladder Cancer

OBJECTIVE: Improvements to bladder cancer risk stratification guidelines are needed to better tailor post-operative surveillance and adjuvant therapy to individual patients. We previously identified STAG2 as a commonly mutated tumor suppressor gene in bladder cancer and an independent predictor of p...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Urol Oncol
Main Authors: Taber, Ann, Park, Youngrok, Lelo, Alana, Prip, Frederik, Xiao, Jerry, Berry, Deborah L., Chaldekas, Krysta, Jensen, Jørgen Bjerggaard, Philips, George, Kim, Jung-Sik, Harris, Brent T., Dyrskjøt, Lars, Waldman, Todd
Formato: Artigo
Idioma:Inglês
Publicado em: 2021
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8286298/
https://ncbi.nlm.nih.gov/pubmed/33712344
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.urolonc.2021.02.007
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados